Multiple sclerosis drugs on Blue Medicare Rx Standard (S5540-002)
Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), North Carolina
- Premium
- $83.90/month
- Deductible
- $615.00, doesn't apply to tier 1
2 of 8 Multiple sclerosis drugs are covered on this plan. All 2 require prior authorization.
6 aren't on the formulary, including teriflunomide and Vumerity.
- $12,157.38Tier 5
- from $35.65Tier 4
Not on the formulary
teriflunomide, Vumerity, fingolimod, Mayzent, Zeposia, Mavenclad
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.